当前位置:首页 - 行情中心 - 赛伦生物(688163) - 财务分析

赛伦生物

(688163)

  

流通市值:8.63亿  总市值:21.05亿
流通股本:4437.20万   总股本:1.08亿

赛伦生物(688163)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.04亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益109889.48万元,未分配利润6090.99万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产111601.70万元,负债1712.21万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入25,621,279.55194,915,924.94173,291,573.0998,058,273.88
营业总成本23,621,291.88143,439,085.68107,900,485.0168,030,894.07
营业利润4,229,440.4151,984,947.7974,286,736.6137,232,787.39
利润总额4,167,899.0650,566,053.1973,631,451.7837,054,710.36
净利润3,757,316.2244,290,403.2862,947,540.7532,307,812.26
其他综合收益----
综合收益总额3,757,316.2244,290,403.2862,947,540.7532,307,812.26
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计912,262,557.85916,362,945.7968,139,753.95938,254,270.74
非流动资产合计203,754,416.6203,671,011.22177,344,744.43193,380,590.95
资产总计1,116,016,974.451,120,033,956.921,145,484,498.381,131,634,861.69
流动负债合计12,171,826.4319,622,194.0821,800,161.2217,990,690.42
非流动负债合计4,950,302.444,911,154.099,526,590.9417,139,753.54
负债合计17,122,128.8724,533,348.1731,326,752.1635,130,443.96
归属于母公司股东权益合计1,098,894,845.581,095,500,608.751,114,157,746.221,096,504,417.73
股东权益合计1,098,894,845.581,095,500,608.751,114,157,746.221,096,504,417.73
负债和股东权益合计1,116,016,974.451,120,033,956.921,145,484,498.381,131,634,861.69
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计12,690,568.94195,256,496.54154,674,633.0668,418,218.26
经营活动现金流出小计33,623,944.9145,003,087.91113,685,246.271,463,418.69
经营活动产生的现金流量净额-20,933,375.9650,253,408.6340,989,386.86-3,045,200.43
投资活动现金流入小计651,473,698.982,994,782,881.472,152,847,874.731,428,644,168.86
投资活动现金流出小计461,722,9602,978,047,892.592,099,761,803.661,382,561,695.04
投资活动产生的现金流量净额189,750,738.9816,734,988.8853,086,071.0746,082,473.82
筹资活动现金流入小计----
筹资活动现金流出小计-35,772,37034,627,20021,642,000
筹资活动产生的现金流量净额--35,772,370-34,627,200-21,642,000
汇率变动对现金及现金等价物的影响-248.06-30,838.3-6,040.2621,270.26
现金及现金等价物净增加额168,817,114.9631,185,189.2159,442,217.6721,416,543.65
期末现金及现金等价物余额350,924,252.18182,107,137.22210,364,165.68172,338,491.66
TOP↑